| Role |
Name |
Disclosure |
Details |
| Author | Jasvinder Chawla, MBBS, MD, MBA, Assistant Professor of Neurology, Director of Neurology Residency Training Program, Assistant Director of Neurology Clerkship Program, Department of Neurology, Loyola University of Chicago Stritch School of Medicine and Loyola University Medical Center | Nothing to disclose | Details | | Coauthor | Daniel H Jacobs, MD, Associate Professor of Neurology, University of Central Florida College of Medicine | Teva Pharmaceutical Biogen Idex Serono EMD Pfizer Berlex | Details | | Medical Editor | Stephen T Gancher, MD, Adjunct Associate Professor, Department of Neurology, Oregon Health Sciences University | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale | Nothing to disclose | Details | | CME Editor | Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital | Nothing to disclose | Details | | Chief Editor | Howard A Crystal, MD, Professor, Departments of Neurology and Pathology, State University of New York Downstate; Consulting Staff, Department of Neurology, University Hospital and Kings County Hospital Center | Pfizer Myriad | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Richard J Caselli, Managing Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Matthew J Baker, CME Editor |
The contributor discloses no conflict of interest. |
|